ZL
Zorica Levkov
Director Of Data Analytics at Luminoso Technologies,
View Zorica's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Director Of Data Analytics
May 2021 - Present · 3 years and 8 months
Company Details
51-200 Employees
Luminoso Daylight™ AI revolutionizes the way you comprehend your customers to improve CSAT scores faster and with pinpoint accuracy. Luminoso Technologies is a global leader in the Natural Language Understanding market. It was born out of the prestigious MIT Media Lab. Our cloud-based platform for text analytics revolutionizes the way organizations uncover insights from conversational and text data like survey submissions, support tickets and product reviews. With support for 14 languages, Luminoso Daylight™ AI preserves the nuance of stories as communicated by customers, employees, and industry voices. Powered by advanced machine learning, our platform goes beyond surface-level understanding by understanding language as well as a human down to the sutble nuances. It uncovers hidden patterns, sentiments, and biases, empowering organizations to make data-driven decisions with confidence. Trusted by Fortune 5000 companies, we nurture human connections that drive critical business strategies. Discover the power of Luminoso and unlock the potential within your textual data. Get Started With A Free Trial Here: https://luminoso.com/trial/
Year Founded
2010
Social Media
LinkedinFacebookTwitter
Industry
Software Development, Software Development Services, IT Services, Business Services
HQ Location
PO Box 51408 Boston, Massachusetts 02205, US
Keywords
SoftwareArtificial Intelligence (AI)Machine LearningCustomer ExperienceVoice of the CustomerVoice of the EmployeeText AnalyticsNLUNatural Language Understandingemployee experience
Discover More About Cleveland Clinic

Find verified contacts of Zorica Levkov in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.